{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:44:38Z","timestamp":1791589478813,"version":"4.3.4"},"reference-count":82,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_162560, CRSII3_160708"],"award-info":[{"award-number":["310030_162560, CRSII3_160708"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-4091-02-2017"],"award-info":[{"award-number":["KFS-4091-02-2017"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000861","name":"Sparks","doi-asserted-by":"publisher","award":["15UOZ01"],"award-info":[{"award-number":["15UOZ01"]}],"id":[{"id":"10.13039\/501100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01658","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T04:28:18Z","timestamp":1511497698000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Epstein\u2013Barr Virus-Specific Immune Control by Innate Lymphocytes"],"prefix":"10.3389","volume":"8","author":[{"given":"Christian","family":"M\u00fcnz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.121.5.761","article-title":"Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"121","author":"Epstein","year":"1964","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci Transl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu Rev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-3-319-22822-8_10","article-title":"Primary immunodeficiencies associated with EBV disease","volume":"390","author":"Cohen","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.ai.2015.03.003","article-title":"Activation and function of iNKT and MAIT cells","volume":"127","author":"Chandra","year":"2015","journal-title":"Adv Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"Gammadelta T cells: first line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.162.6.1745","article-title":"Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism","volume":"162","author":"Ljunggren","year":"1985","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/eji.1830240613","article-title":"Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells","volume":"24","author":"Correa","year":"1994","journal-title":"Eur J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.2910160204","article-title":"Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity","volume":"16","author":"Herberman","year":"1975","journal-title":"Int J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1084\/jem.147.5.1314","article-title":"Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis","volume":"147","author":"Trinchieri","year":"1978","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: a role for natural killer cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1005286","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PLoS Pathog"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting edge: NKG2ChiCD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","article-title":"Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence","volume":"116","author":"Strowig","year":"2010","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-3083.2007.01980.x","article-title":"The expression of human natural killer cell receptors in early life","volume":"66","author":"Sundstrom","year":"2007","journal-title":"Scand J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1172\/JCI86923","article-title":"Cognate HLA absence in trans diminishes human NK cell education","volume":"126","author":"Landtwing","year":"2016","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MOH.0b013e32835423c3","article-title":"Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant","volume":"19","author":"Velardi","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1084\/jem.20161017","article-title":"Two alternate strategies for innate immunity to Epstein-Barr virus: one using NK cells and the other NK cells and gammadelta T cells","volume":"214","author":"Djaoud","year":"2017","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2017.06.004","article-title":"The ambiguous role of gammadelta T lymphocytes in antitumor immunity","volume":"38","author":"Chitadze","year":"2017","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt\u2019s lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","article-title":"Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients","volume":"190","author":"Babcock","year":"1999","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1004746","DOI":"10.1371\/journal.ppat.1004746","article-title":"Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children","volume":"11","author":"Jayasooriya","year":"2015","journal-title":"PLoS Pathog"},{"key":"B37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human Vgamma9Vdelta2-T cells controls Epstein-Barr virus-induced B cell lymphoproliferative disease","volume":"26","author":"Xiang","year":"2014","journal-title":"Cancer Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"93179","DOI":"10.1172\/jci.insight.93179","article-title":"Adoptively transferred Vgamma9Vdelta2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model","volume":"2","author":"Zumwalde","year":"2017","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7935","DOI":"10.1158\/0008-5472.CAN-09-0828","article-title":"EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies","volume":"69","author":"Yuling","year":"2009","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","article-title":"Innate immune control of EBV-infected B cells by invariant natural killer T cells","volume":"122","author":"Chung","year":"2013","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cyto.b.20376","article-title":"Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia","volume":"74","author":"Hudnall","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"B42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e01677","DOI":"10.1128\/JVI.01677-16","article-title":"The long and complicated relationship between Epstein-Barr virus and epithelial cells","volume":"91","author":"Hutt-Fletcher","year":"2017","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","volume":"95","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10875-015-0168-y","article-title":"Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1)","volume":"35","author":"Cohen","year":"2015","journal-title":"J Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","article-title":"X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis","volume":"149","author":"Speckmann","year":"2013","journal-title":"Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nm1189","article-title":"Regulation of NKT cell development by SAP, the protein defective in XLP","volume":"11","author":"Nichols","year":"2005","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.20042432","article-title":"Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product","volume":"201","author":"Pasquier","year":"2005","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/leu.2011.371","article-title":"Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases","volume":"26","author":"Linka","year":"2012","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach","volume":"96","author":"Stepensky","year":"2011","journal-title":"Haematologica"},{"key":"B59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000333472","article-title":"IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection","volume":"158","author":"Mansouri","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s10875-014-0110-8","article-title":"Interleukin-2-inducible T-cell kinase (ITK) deficiency \u2013 clinical and molecular aspects","volume":"34","author":"Ghosh","year":"2014","journal-title":"J Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/his.12677","article-title":"High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency","volume":"67","author":"Bienemann","year":"2015","journal-title":"Histopathology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/pbc.25648","article-title":"ITK deficiency: how can EBV be treated before lymphoma?","volume":"62","author":"Cipe","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/bmt.2016.185","article-title":"Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other","volume":"52","author":"Cagdas","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","article-title":"Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection","volume":"214","author":"Izawa","year":"2017","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2011.11.013","article-title":"CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia","volume":"129","author":"van Montfrans","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3324\/haematol.2012.068791","article-title":"Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27","volume":"98","author":"Salzer","year":"2013","journal-title":"Haematologica"},{"key":"B68","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","article-title":"Novel mutations in TNFRSF7\/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency","volume":"136","author":"Alkhairy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","article-title":"Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease","volume":"35","author":"Dhalla","year":"2015","journal-title":"J Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","article-title":"Large deletion of MAGT1 gene in a patient with classic Kaposi sarcoma, CD4 lymphopenia, and EBV infection","volume":"37","author":"Brigida","year":"2017","journal-title":"J Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","article-title":"NF-kappaB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation","volume":"36","author":"Boztug","year":"2016","journal-title":"J Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.3324\/haematol.2016.145136","article-title":"Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans","volume":"101","author":"Schipp","year":"2016","journal-title":"Haematologica"},{"key":"B75","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1086\/503269","article-title":"A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8","volume":"78","author":"Eidenschenk","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI61014","article-title":"Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency","volume":"122","author":"Gineau","year":"2012","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V88.8.3022.bloodjournal8883022","article-title":"Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections","volume":"88","author":"de Vries","year":"1996","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/ni.3575","article-title":"RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics","volume":"17","author":"Salzer","year":"2016","journal-title":"Nat Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2013.01.042","article-title":"Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation","volume":"131","author":"Moshous","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nature13386","article-title":"CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation","volume":"510","author":"Martin","year":"2014","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T18:00:38Z","timestamp":1603389638000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2017.01658"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01658","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]},"article-number":"1658"}}